Community news

Amidst our bustling science park, with 2,800 employees in 180 businesses, there’s always something happening. Here, we gather news from both Medicon Village and our members.

Cellevate

Cellevate to announce major advances in yield and scalability of viral vaccine production at World Vaccine Congress

Cellevate to announce major advances in yield and scalability of viral vaccine production at World Vaccine Congress Europe with global launch of Cellevat3d® VAX nanofiber microcarriers >13-fold higher infectious viral vaccine titers in Vero cell cultures compared to industry-standard microcarriers 11.4-fold higher infectious enterovirus vaccine titers demonstrated in HEK293T cultures…

Medicon Village

Medicon Village Investor Panel connects life science companies with leading investors

Last Wednesday, Medicon Village hosted its very first Medicon Village Investor Panel, bringing together eight innovative life science companies with a distinguished panel of Nordic and international investors. The initiative aims to strengthen investment readiness among early- and growth-stage companies while creating a platform for meaningful dialogue between entrepreneurs and…

Xintela

Xintela announces subsidiary Targinta collaboration with MSK Therapeutics Accelerator

Xintela announces that Xintela’s oncology subsidiary, Targinta AB, has today initiated a collaboration with Memorial Sloan Kettering Cancer Center’s (MSK’s) Therapeutics Accelerator in New York, USA, for development of its integrin α10β1 antibody therapeutic in patients with aggressive sarcoma. Under the collaboration, Targinta will produce antibodies targeting integrin α10β1 and…